These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32115315)

  • 41. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.
    Bradford DW; Perkins DO; Lieberman JA
    Drugs; 2003; 63(21):2265-83. PubMed ID: 14524730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
    Hui CL; Wong AK; Leung WW; Lee EH; Chan SK; Chang WC; Chen EY; Chan TC; Swapna V; Tagata H; Tsujino N; Nemoto T; Mizuno M; Kang NI; Kim SW; Chung YC
    Early Interv Psychiatry; 2019 Dec; 13(6):1329-1337. PubMed ID: 30485671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
    Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
    Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
    Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
    J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
    Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
    BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
    Wunderink L; van Bebber J; Sytema S; Boonstra N; Meijer RR; Wigman JTW
    Schizophr Res; 2020 Feb; 216():192-199. PubMed ID: 31866076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong.
    Hui CL; Tang JY; Leung CM; Wong GH; Chang WC; Chan SK; Lee EH; Chen EY
    Aust N Z J Psychiatry; 2013 Aug; 47(8):746-53. PubMed ID: 23612934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.
    Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S
    Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic strategies in the first psychotic episode].
    Douki S; Taktak MJ; Ben Zineb S; Cheour M
    Encephale; 1999 Nov; 25 Spec No 3():44-51. PubMed ID: 10598294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic consequences of alternative medication strategies in first episode non-affective psychosis.
    Stant AD; TenVergert EM; Wunderink L; Nienhuis FJ; Wiersma D
    Eur Psychiatry; 2007 Sep; 22(6):347-53. PubMed ID: 17418538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up.
    Gotfredsen DR; Wils RS; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AAE; Mors O; Nordentoft M
    Psychol Med; 2017 Sep; 47(12):2118-2129. PubMed ID: 28382874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is a higher dose of antipsychotic medication required to treat a relapse following discontinuation in first episode psychosis?
    Bowtell M; McGorry P; O'Donoghue B
    Schizophr Res; 2019 Feb; 204():407-408. PubMed ID: 30076110
    [No Abstract]   [Full Text] [Related]  

  • 56. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
    O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
    Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visual working memory deterioration preceding relapse in psychosis.
    Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
    Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders.
    Harrow M; Jobe TH; Tong L
    Psychol Med; 2022 Oct; 52(13):2681-2691. PubMed ID: 33550993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.
    Levi L; Bar-Haim M; Winter-van Rossum I; Davidson M; Leucht S; Fleischhacker WW; Park J; Davis JM; Kahn RS; Weiser M
    Schizophr Bull; 2023 Jul; 49(4):903-913. PubMed ID: 36999551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal relapse pattern of patients with first-episode schizophrenia-spectrum disorders and its predictors and outcomes: A 10-year follow-up study.
    Chan SKW; Chan HYV; Liao Y; Suen YN; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Asian J Psychiatr; 2022 May; 71():103087. PubMed ID: 35299139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.